Matches in Wikidata for { <http://www.wikidata.org/entity/Q83164419> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q83164419 description "artículu científicu espublizáu en marzu de 2006" @default.
- Q83164419 description "scientific article published on 01 March 2006" @default.
- Q83164419 description "wetenschappelijk artikel" @default.
- Q83164419 description "наукова стаття, опублікована в березні 2006" @default.
- Q83164419 name "In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab" @default.
- Q83164419 name "In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab" @default.
- Q83164419 type Item @default.
- Q83164419 label "In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab" @default.
- Q83164419 label "In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab" @default.
- Q83164419 prefLabel "In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab" @default.
- Q83164419 prefLabel "In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab" @default.
- Q83164419 P1433 Q83164419-066D07BD-0880-4BC0-8AA0-9D1EEE7F3A9E @default.
- Q83164419 P1476 Q83164419-60062BA3-EB74-4887-BD44-9B3D5898C956 @default.
- Q83164419 P2093 Q83164419-0DD9EA1F-4E1A-49C7-B36C-CA0B6D1D6721 @default.
- Q83164419 P2093 Q83164419-14E2D3B7-177A-46FF-80A6-C842D8083988 @default.
- Q83164419 P2093 Q83164419-2E4D0D57-FA98-4F68-ADCD-07CC2A58B43C @default.
- Q83164419 P2093 Q83164419-3FE0E5F5-F767-4A88-9BAA-A779DCC41EE0 @default.
- Q83164419 P2093 Q83164419-5F2AC2DC-22EE-40FC-B28D-C9434C8B52B4 @default.
- Q83164419 P2093 Q83164419-7F566C6D-1642-4B91-9F82-3031D38CE327 @default.
- Q83164419 P304 Q83164419-15696E94-8E0A-4267-A004-FEA43A923C7B @default.
- Q83164419 P31 Q83164419-DB48E85A-1C98-4EB2-B017-892C8F6BF218 @default.
- Q83164419 P433 Q83164419-8E0EFCD2-A0B3-4594-810B-C7935E3C92F8 @default.
- Q83164419 P478 Q83164419-ED7C1E5A-EF14-4100-9384-E1B6E2EBBB3F @default.
- Q83164419 P50 Q83164419-22CF472F-7E87-4980-977E-31D9A7D7E8B2 @default.
- Q83164419 P577 Q83164419-0E923D93-DDFD-4393-BA4C-9C3C3AD93A08 @default.
- Q83164419 P698 Q83164419-C874ECA0-BE44-4E61-8271-1FE1848A9D1F @default.
- Q83164419 P921 Q83164419-117282CB-249C-430B-A496-3E599130AA49 @default.
- Q83164419 P921 Q83164419-6A5BBB95-4606-43F4-90E4-C903282577BF @default.
- Q83164419 P921 Q83164419-EE449075-0FAD-4684-92F4-BDF263EE97E0 @default.
- Q83164419 P698 16619542 @default.
- Q83164419 P1433 Q326290 @default.
- Q83164419 P1476 "In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab" @default.
- Q83164419 P2093 "Dagmar E Ettlinger" @default.
- Q83164419 P2093 "Eva Ostermann" @default.
- Q83164419 P2093 "Johann Schueller" @default.
- Q83164419 P2093 "Markus Mitterhauser" @default.
- Q83164419 P2093 "Martin Czejka" @default.
- Q83164419 P2093 "Wolfgang Wadsak" @default.
- Q83164419 P304 "1337-1341" @default.
- Q83164419 P31 Q13442814 @default.
- Q83164419 P433 "2B" @default.
- Q83164419 P478 "26" @default.
- Q83164419 P50 Q83040585 @default.
- Q83164419 P577 "2006-03-01T00:00:00Z" @default.
- Q83164419 P698 "16619542" @default.
- Q83164419 P921 Q412197 @default.
- Q83164419 P921 Q420296 @default.
- Q83164419 P921 Q422248 @default.